市場調査レポート

商品コード

1317958

ヒトインスリン製剤市場：製品タイプ、ブランド、薬剤、デリバリーデバイス、用途別-2023～2030年の世界予測

Human Insulin Drugs Market by Product Type, Brands, Drugs, Delivery Devices, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

ヒトインスリン製剤の世界市場は、2023年に509億2,000万米ドル、CAGR 10.66%で大幅な成長が予測され、2030年には1,039億7,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のヒトインスリン製剤市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ヒトインスリン製剤の世界市場規模および予測は？

2.予測期間中、世界のヒトインスリン製剤市場を形成するCOVID-19の阻害要因と影響は？

3.ヒトインスリン製剤の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.ヒトインスリン製剤の世界市場における競争戦略は？

5.ヒトインスリン製剤の世界市場における技術動向と規制の枠組みは？

6.ヒトインスリン製剤の世界市場における主要ベンダーの市場シェアは？

7.ヒトインスリン製剤の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 世界中で糖尿病患者の有病率が上昇
  - 高齢者および肥満人口の大幅な増加
  - さまざまなドラッグデリバリー方法の採用
- 抑制要因
  - ヒトインスリン製剤に関連する高コスト
- 機会
  - インスリンバイオシミラーの新たな規制
  - ヒトインスリン製剤の研究開発への継続的な投資
- 課題
  - 承認に関する厳しい規制基準
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章ヒトインスリン製剤市場：製品タイプ別

イントロダクション
基礎インスリンまたは持効性インスリン
バイオシミラーインスリン
混合インスリン
速効型インスリン
従来型ヒトインスリン

第7章ヒトインスリン製剤市場：ブランド別

イントロダクション
ヒューマログ
ランタス
ノボラピッド

第8章ヒトインスリン製剤市場：薬剤別

イントロダクション
生物製剤
バイオシミラー

第9章ヒトインスリン製剤市場：デリバリーデバイス別

イントロダクション
ペンニードル
ペン
注射器

第10章ヒトインスリン製剤市場：用途別

イントロダクション
1型糖尿病
2型糖尿病

第11章南北アメリカのヒトインスリン製剤市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域のヒトインスリン製剤市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカのヒトインスリン製剤市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第15章掲載企業一覧

第16章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. HUMAN INSULIN DRUGS MARKET RESEARCH PROCESS
FIGURE 2. HUMAN INSULIN DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. HUMAN INSULIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
FIGURE 5. HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2022 VS 2030 (%)
FIGURE 6. HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2022 VS 2030 (%)
FIGURE 7. HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2022 VS 2030 (%)
FIGURE 8. HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 9. HUMAN INSULIN DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. HUMAN INSULIN DRUGS MARKET DYNAMICS
FIGURE 11. HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. HUMAN INSULIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. HUMAN INSULIN DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. HUMAN INSULIN DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. HUMAN INSULIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 5. HUMAN INSULIN DRUGS MARKET SIZE, BY BASAL OR LONG-ACTING INSULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. HUMAN INSULIN DRUGS MARKET SIZE, BY BIOSIMILAR INSULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HUMAN INSULIN DRUGS MARKET SIZE, BY COMBINATION INSULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HUMAN INSULIN DRUGS MARKET SIZE, BY FAST-ACTING INSULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HUMAN INSULIN DRUGS MARKET SIZE, BY TRADITIONAL HUMAN INSULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 11. HUMAN INSULIN DRUGS MARKET SIZE, BY HUMALOG, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HUMAN INSULIN DRUGS MARKET SIZE, BY LANTUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HUMAN INSULIN DRUGS MARKET SIZE, BY NOVORAPID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 15. HUMAN INSULIN DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. HUMAN INSULIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 18. HUMAN INSULIN DRUGS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. HUMAN INSULIN DRUGS MARKET SIZE, BY PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. HUMAN INSULIN DRUGS MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 42. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 43. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 44. CANADA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 49. MEXICO HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 69. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 70. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 71. CHINA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 74. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 75. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 76. INDIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 86. JAPAN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 116. THAILAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 132. DENMARK HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 137. EGYPT HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 142. FINLAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 147. FRANCE HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 152. GERMANY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 160. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 161. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 162. ITALY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 177. NORWAY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 180. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 182. POLAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 185. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 186. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 187. QATAR HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 207. SPAIN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 222. TURKEY HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY BRANDS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM HUMAN INSULIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. HUMAN INSULIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 234. HUMAN INSULIN DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 235. HUMAN INSULIN DRUGS MARKET LICENSE & PRICING

Product Code: MRR-957C47F9223E

The Global Human Insulin Drugs Market is forecasted to grow significantly, with a projected USD 50.92 billion in 2023 at a CAGR of 10.66% and expected to reach a staggering USD 103.97 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Human Insulin Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Human Insulin Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Basal or Long-Acting Insulins, Biosimilar Insulins, Combination Insulins, Fast-Acting Insulins, and Traditional Human Insulins. The Traditional Human Insulins is projected to witness significant market share during forecast period.

Based on Brands, market is studied across Humalog, Lantus, and NovoRapid. The Lantus is projected to witness significant market share during forecast period.

Based on Drugs, market is studied across Biologics and Biosimilars. The Biosimilars is projected to witness significant market share during forecast period.

Based on Delivery Devices, market is studied across Pen Needles, Pens, and Syringes. The Syringes is projected to witness significant market share during forecast period.

Based on Application, market is studied across Type 1 Diabetes and Type 2 Diabetes. The Type 1 Diabetes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Human Insulin Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Insulin Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Insulin Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Insulin Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Human Insulin Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Human Insulin Drugs Market?

6. What is the market share of the leading vendors in the Global Human Insulin Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Insulin Drugs Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Human Insulin Drugs Market, by Product Type, 2022 vs 2030
4.3. Human Insulin Drugs Market, by Brands, 2022 vs 2030
4.4. Human Insulin Drugs Market, by Drugs, 2022 vs 2030
4.5. Human Insulin Drugs Market, by Delivery Devices, 2022 vs 2030
4.6. Human Insulin Drugs Market, by Application, 2022 vs 2030
4.7. Human Insulin Drugs Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of dibetic patient all over the globe
  - 5.1.1.2. Significant growth of geriatric and obese population
  - 5.1.1.3. Adoption of different drug delivery methods
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with human insulin drugs
- 5.1.3. Opportunities
  - 5.1.3.1. New regulations for insulin biosimilars
  - 5.1.3.2. Ongoing investments in R&D of human insulin drugs
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory norms for approvals
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Human Insulin Drugs Market, by Product Type

6.1. Introduction
6.2. Basal or Long-Acting Insulins
6.3. Biosimilar Insulins
6.4. Combination Insulins
6.5. Fast-Acting Insulins
6.6. Traditional Human Insulins

7. Human Insulin Drugs Market, by Brands

7.1. Introduction
7.2. Humalog
7.3. Lantus
7.4. NovoRapid

8. Human Insulin Drugs Market, by Drugs

8.1. Introduction
8.2. Biologics
8.3. Biosimilars

9. Human Insulin Drugs Market, by Delivery Devices

9.1. Introduction
9.2. Pen Needles
9.3. Pens
9.4. Syringes

10. Human Insulin Drugs Market, by Application

10.1. Introduction
10.2. Type 1 Diabetes
10.3. Type 2 Diabetes

11. Americas Human Insulin Drugs Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Human Insulin Drugs Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Human Insulin Drugs Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

ヒトインスリン製剤市場：製品タイプ、ブランド、薬剤、デリバリーデバイス、用途別-2023～2030年の世界予測

Human Insulin Drugs Market by Product Type, Brands, Drugs, Delivery Devices, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 ヒトインスリン製剤市場：製品タイプ別

第7章 ヒトインスリン製剤市場：ブランド別

第8章 ヒトインスリン製剤市場：薬剤別

第9章 ヒトインスリン製剤市場：デリバリーデバイス別

第10章 ヒトインスリン製剤市場：用途別

第11章 南北アメリカのヒトインスリン製剤市場

第12章 アジア太平洋地域のヒトインスリン製剤市場

第13章 欧州・中東・アフリカのヒトインスリン製剤市場

第14章 競合情勢

第15章 掲載企業一覧

第16章 付録